Find information on thousands of medical conditions and prescription drugs.

Zoledronic acid

Zoledronate (Zometa®, Novartis) is a bisphosphonate, used to prevent osteoporosis and skeletal fractures, particularly in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia, particularly hypercalcemia of malignancy. It can also be helpful for treating pain from bone metastases. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Zafirlukast
Zagam
Zalcitabine
Zaleplon
Zanaflex
Zanamivir
Zantac
Zarontin
Zelnorm
Zerit
Zestoretic
Zestril
Zetia
Zevalin
Ziagen
Zidovudine
Zileuton
Ziprasidone
Zithromax
Zocor
Zofran
Zoladex
Zoledronic acid
Zolmitriptan
Zoloft
Zolpidem
Zometa
Zomig
Zonegran
Zonisamide
Zopiclone
Zosyn
Zovia
Zovirax
Zyban
Zymar
Zyprexa
Zyrtec
Zyvox

Administration

Usually 4 mg intravenously once a month when given for oncologic purposes. It is given once a year for treatment of osteoporosis.

Side effects

Side effects can include fatigue, anemia, muscle aches, fevers, and swelling in the feet or legs. Zoledronate can cause deterioration in renal function.

A rare complicaiton of zoledronate is osteonecrosis of the jaw. This has mainly been seen in patients with multiple myeloma treated with zoledronate (Durie et al 2005).

Contraindications

  • Poor renal function (e.g. creatinine>3 mg/dL)
  • Pregnancy

Reference

  • Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005;353:99-102. PMID 16000365.

Read more at Wikipedia.org


[List your site here Free!]


Drugs for Paget's disease yield good results.(Rheumatology) : An article from: Internal Medicine News $5.95 Zoledronic acid sustains bone in breast ca patients.(Women's Health) : An article from: Family Practice News $5.95
Zoledronic acid protects bone in breast Ca patients: prophylactic treatment may avert osteoporosis and fractures resulting from aromatase inhibitor therapy.(Women's ... : An article from: Internal Medicine News $5.95 Zoledronic acid protects bone in premenopausal patients with breast ca.(Gynecology) : An article from: OB GYN News $5.95
Zoledronic acid inhibits osteoclastogenesis in vitro and in a mouse model of inflammatory osteolysis : An article from: The Annals of Otology, Rhinology & Laryngology $10.00

Zoledronic acid causes enhancement of bone growth into porous implants
The effect of zoledronic acid on bone ingrowth was examined in an animal model in which porous tantalum implants were placed bilaterally within the ulnae ...
Zoledronic acid: Annual IV may equal daily oral Tx for osteoporosis - Gyneology
Intermittent infusions of the biophosphate zoledronic acid in postmenopausal women--with dosages as far apart as 12 months--increase bone density and ...
Head-to-Head Study in The New England Journal of Medicine Finds a Single Infusion of Zoledronic Acid More Effective Than Daily Risedronate Tablets in Treating
Novel investigational agent found more effective, longer lasting with faster onset of action than current standard treatment EAST HANOVER, N.J., Aug.
Multimedia Available/FDA Approves Novartis Drug ZOMETA — Zoledronic Acid for Injection — for the Treatment of Cancer-Related Bone Complications
Business Editors & Health/Medical Writers ADVISORY...for FRIDAY (Feb. 22) NOTE TO EDITORS: Multimedia Assets Available With This Story Include ...
Long-term bisphosphonate use may damage jaw
Prolonged use of bisphosphonate therapy can lead to osteonecrosis of the jaw--a previously unrecognized and potentially serious complication that can ...
Volunteers needed for trial - FYI
Investigators are recruiting volunteers for a trial of a once-yearly infusion of zole-dronic acid for the treatment of osteoporosis. The program also ...
Abstract 3054: Cancer Patients With Bone Complications Overwhelmingly Prefer Infusion of Zoledronic Acid Over Pamidronate
A new study shows that patients strongly prefer zoledronic acid to pamidronate for the treatment of bone metastases that stem from various different cancer types. In the study, 89% of patients spec
FDA Advisory Committee Recommends Approval Of Novartis Drug ZOMETA(R) (Zoledronic Acid For Injection) For The Treatment Of Cancer-Related Bone Complications
Novartis announced today that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) recommended approval of ZOMETA(R) ...

Home Contact Resources Exchange Links ebay